Mechanisms and implications of epithelial cell plasticity in the bladder.
Cellular plasticity, the ability of cells to reprogramme and alter their fate, has a pivotal role in maintaining homeostasis and facilitating tissue regeneration after injury.
APA
Wu K, Liu X, et al. (2026). Mechanisms and implications of epithelial cell plasticity in the bladder.. Nature reviews. Urology, 23(2), 70-88. https://doi.org/10.1038/s41585-025-01066-y
MLA
Wu K, et al.. "Mechanisms and implications of epithelial cell plasticity in the bladder.." Nature reviews. Urology, vol. 23, no. 2, 2026, pp. 70-88.
PMID
40707815
Abstract
Cellular plasticity, the ability of cells to reprogramme and alter their fate, has a pivotal role in maintaining homeostasis and facilitating tissue regeneration after injury. The bladder urothelium, a dynamic transitional epithelial layer, displays a highly plastic phenotype that enables its remarkable regenerative capacity in response to wounding. During both development and repair, urothelial cells exhibit considerable plasticity through processes such as dedifferentiation, transdifferentiation and epithelial-to-mesenchymal transition. Urothelial plasticity is not only crucial for healthy tissue repair but is also involved in pathological conditions, including cancer. In bladder tumorigenesis, urothelial cells exploit plasticity to acquire new phenotypic and functional characteristics, transitioning between distinct cellular states. This plasticity contributes to tumour heterogeneity, subtype switching, progression, metastasis and resistance to therapies. These dynamic cellular transitions are regulated by intrinsic and extrinsic factors, including transcriptional and epigenetic mechanisms, as well as microenvironmental influences. Targeting urothelial plasticity could offer novel therapeutic strategies for bladder-related diseases.
MeSH Terms
Humans; Cell Plasticity; Urinary Bladder; Epithelial Cells; Urothelium; Urinary Bladder Neoplasms; Epithelial-Mesenchymal Transition; Animals
같은 제1저자의 인용 많은 논문 (5)
- Validation of the MTXPK Tool in Predicting Glucarpidase Utilization Among Patients With Delayed Methotrexate Clearance: A Retrospective Study.
- Gd-EOB-DTPA-enhanced MRI radiomics and deep learning models for predicting the pathological differentiation degree in hepatocellular carcinoma.
- Development and external validation of nomograms for predicting prostate cancer and clinically significant prostate cancer in patients with PSA between 4 and 20 ng/mL.
- Targeting FSP1 triggers ferroptosis in lung cancer.
- Analyses of the Coexpression of Lactate Metabolism- and Ferroptosis-Related Genes in Hepatocellular Carcinoma.